Genocea develops both prophylactic and therapeutics vaccines for infectious diseases. Their technology screens antigens that result in the in vivo stimulation of protective CD8+ and CD4+ T-cells.
Genocea Biosciences
Business
Address
Facts from the Community
From the BioVenturist base
Medical focus:
Investment Round:
| Investment round | Amount raised | Currency | Date | Investors | web reference |
|---|---|---|---|---|---|
|
|
We can also tell you Genocea Biosciences is a…
If you know more about Genocea Biosciences, you can add more facts here »
